We proudly share feedback from the portfolio of world-leading university spinout companies we work closely with.


iotaSciences is grateful for the continuing support of Oxford Investment Consultants as it moves to the next phase of development. In addition to being a pleasure to work with, and respecting timelines, the OIC principal is well informed and came with a deep knowledge of young, technology-based spinout companies; and importantly was always willing to share this knowledge in a direct way.

Learn more about iotaSciences here.

Prof Edmond Walsh, CEO
— Prof Edmond Walsh, CEO

Mind Foundry

Mind Foundry is lucky to have had OIC’s support since its inception; support that has proved invaluable throughout the three-year journey to date. The experienced OIC team has always seemed to get what Mind Foundry is about, both technically and culturally, and reliably provided both wise advice and capital, which have helped buttress the Company’s rapid growth.

Learn more about Mind Foundry here.

Profs Steve Roberts & Michael Osborne, Academic Founders
— Profs Steve Roberts & Michael Osborne, Academic Founders

Orbit Discovery

As a rapidly growing company with grand plans, Orbit Discovery continues to benefit from direct input from OIC, their broader network and interactions with other portfolio companies. Their ongoing research ensures they are well aware of the Oxford/Cambridge ecosystem and their willingness to share that knowledge is of great value and hugely appreciated.

Learn more about Orbit Discovery here.

Alex Batchelor, CEO
— Alex Batchelor, CEO


OrganOx, like many companies in the Oxford Ecosystem, can attribute its existence and success to the support received from Oxford Investment Consultants. I have found the OIC team to work closely with the businesses it has invested in, providing capital and guidance on the journey from start-up to scale-up.

Learn more about OrganOx here.

Craig Marshall, CEO
— Craig Marshall, CEO

Oxford Endovascular

Oxford Investment Consultants have been a pleasure to work with, supporting Oxford Endovascular through its fundraise with an efficient due diligence process and informed questions. The OIC team has always been on hand to discuss issues and offer helpful advice. OIC is an investor that takes a strong interest in the business and remains true to its word.

Learn more about Oxford Endovascular here.

Mike Karim, CEO
— Mike Karim, CEO